HK1025506A1 - Pharmaceutical products for curing and preventing diseases resulting from the damaging of the vascular endothelial cells - Google Patents

Pharmaceutical products for curing and preventing diseases resulting from the damaging of the vascular endothelial cells

Info

Publication number
HK1025506A1
HK1025506A1 HK00103903A HK00103903A HK1025506A1 HK 1025506 A1 HK1025506 A1 HK 1025506A1 HK 00103903 A HK00103903 A HK 00103903A HK 00103903 A HK00103903 A HK 00103903A HK 1025506 A1 HK1025506 A1 HK 1025506A1
Authority
HK
Hong Kong
Prior art keywords
pct
endothelial cells
damaging
curing
vascular endothelial
Prior art date
Application number
HK00103903A
Other languages
English (en)
Inventor
Andrea Jednakovits
Laszlo Ueroegdi
Ede Marvanyos
Mihaly Barabas
Istvan Kurucz
Erno Bacsy
Laszlo Koranyi
Sandor Erdo
Gyorgy Dorman
Marta Vitai
Gyorgy Schmidt
Marta Sinka
Magdolna Rorok
Original Assignee
Cytrx Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU9602204A external-priority patent/HUP9602204D0/hu
Priority claimed from HU9701349A external-priority patent/HUP9701349A1/hu
Application filed by Cytrx Corp filed Critical Cytrx Corp
Publication of HK1025506A1 publication Critical patent/HK1025506A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK00103903A 1996-08-09 2000-06-28 Pharmaceutical products for curing and preventing diseases resulting from the damaging of the vascular endothelial cells HK1025506A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU9602204A HUP9602204D0 (en) 1996-08-09 1996-08-09 Pharmaceutical compositions for treating diseases connected with the disfunction of the vascular endothelial cells
HU9701349A HUP9701349A1 (hu) 1997-08-04 1997-08-04 Gyógyászati készítmények a vaszkuláris endoteliális sejtek rendellenes működésével összefüggő betegségek gyógyítására vagy megelőzésére
PCT/HU1997/000044 WO1998006400A2 (fr) 1996-08-09 1997-08-06 Produits pharmaceutiques preventifs et curatifs de maladies liees a des defaillances de cellules de l'endothelium vasculaire

Publications (1)

Publication Number Publication Date
HK1025506A1 true HK1025506A1 (en) 2000-11-17

Family

ID=90014231

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00103903A HK1025506A1 (en) 1996-08-09 2000-06-28 Pharmaceutical products for curing and preventing diseases resulting from the damaging of the vascular endothelial cells

Country Status (20)

Country Link
US (1) US6143741A (fr)
EP (1) EP0966283B1 (fr)
JP (1) JP2001504446A (fr)
AT (1) ATE329592T1 (fr)
AU (1) AU739614B2 (fr)
BG (1) BG64456B1 (fr)
CA (1) CA2262997C (fr)
CZ (1) CZ298542B6 (fr)
DE (1) DE69736130T2 (fr)
DK (1) DK0966283T3 (fr)
EE (1) EE04044B1 (fr)
ES (1) ES2267148T3 (fr)
HK (1) HK1025506A1 (fr)
IL (1) IL128256A (fr)
NO (1) NO325109B1 (fr)
PT (1) PT966283E (fr)
RS (1) RS49719B (fr)
SK (1) SK284301B6 (fr)
UA (1) UA64716C2 (fr)
WO (1) WO1998006400A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU9701081D0 (en) 1997-06-23 1997-08-28 Gene Research Lab Inc N Pharmaceutical composition of antitumoral activity
HU226617B1 (en) * 1998-12-14 2009-04-28 Cytrx Corp Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, and pharmaceutical composition containing the compound as active ingredient
HUP9900475D0 (en) * 1999-02-26 1999-04-28 Biorex Kutato Fejlesztoe Kft O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component
NZ533795A (en) 2002-01-11 2006-03-31 Biorex Kutato Fejlesztoe Kft Carboxamidine derivatives and their use in the treatment of vascular diseases
HUP0303584A3 (en) 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
TW200831479A (en) * 2006-09-26 2008-08-01 Cytrx Corp Pharmaceutical compositions and methods for treating diseases
CA2671049A1 (fr) * 2006-12-01 2008-06-12 Cytrx Corporation Retablissement apres une attaque
TW200901958A (en) * 2007-05-04 2009-01-16 Cytrx Corp Diabetic wound healing
JP5429865B2 (ja) * 2009-09-15 2014-02-26 学校法人日本大学 生体外創傷治癒試験用用具または創傷作製方法
HUP1100535A2 (en) * 2011-09-26 2013-04-29 Bracelia Invest Ltd Pharmaceutical composition for enhancement of stem cell treatment
US9802927B2 (en) 2015-06-10 2017-10-31 Denali Therapeutics, Inc. Oxadiazine compounds and methods of use thereof
KR20230128462A (ko) 2020-11-19 2023-09-05 제브라 덴마크 에이/에스 아리모클로몰 시트레이트 및 이의 중간체를 제조하기 위한 공정

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4187220A (en) * 1977-08-30 1980-02-05 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
HU207988B (en) * 1988-10-20 1993-07-28 Biorex Kutato Fejlesztoe Kft Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
GB9017351D0 (en) * 1990-08-08 1990-09-19 Wellcome Found Medicaments for treatment of atherosclerosis
WO1995030649A1 (fr) * 1994-05-06 1995-11-16 Biorex Kutató És Fejleszto^' Rt. Nouveaux derives d'acide hydroximique, compositions pharmaceutiques les contenant, et leur procede de preparation
HU218480B (hu) * 1995-06-15 2000-09-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
HU222994B1 (hu) * 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására

Also Published As

Publication number Publication date
DE69736130D1 (de) 2006-07-27
IL128256A (en) 2004-05-12
EE04044B1 (et) 2003-06-16
SK15499A3 (en) 2000-02-14
YU5199A (sh) 2000-10-30
EE9900044A (et) 1999-08-16
DE69736130T2 (de) 2007-01-04
UA64716C2 (en) 2004-03-15
ATE329592T1 (de) 2006-07-15
AU3704997A (en) 1998-03-06
SK284301B6 (sk) 2005-01-03
CZ298542B6 (cs) 2007-10-31
DK0966283T3 (da) 2006-10-09
NO990547D0 (no) 1999-02-05
EP0966283A2 (fr) 1999-12-29
BG64456B1 (bg) 2005-03-31
BG103194A (en) 1999-09-30
IL128256A0 (en) 2000-02-17
NO325109B1 (no) 2008-02-04
RS49719B (sr) 2007-12-31
EP0966283B1 (fr) 2006-06-14
CZ43599A3 (cs) 1999-07-14
WO1998006400A3 (fr) 1998-03-26
ES2267148T3 (es) 2007-03-01
WO1998006400A2 (fr) 1998-02-19
CA2262997A1 (fr) 1998-02-19
NO990547L (no) 1999-03-25
AU739614B2 (en) 2001-10-18
CA2262997C (fr) 2008-07-29
PT966283E (pt) 2006-08-31
US6143741A (en) 2000-11-07
JP2001504446A (ja) 2001-04-03

Similar Documents

Publication Publication Date Title
MY106259A (en) 2-aminopyrimidinone derivatives.
ZA922614B (en) Benzopyrones
UA48946C2 (uk) Арилалкілдіазинони, спосіб їх одержання (варіанти), фармацевтичний склад, спосіб його одержання та спосіб лікування
ATE252080T1 (de) Indolin-2-one derivate, verfahren zu ihrer herstellung und dieseenthaltende arzneimittel
AU6017296A (en) Isocoumarin derivatives and use thereof in drugs
HK1025506A1 (en) Pharmaceutical products for curing and preventing diseases resulting from the damaging of the vascular endothelial cells
ATE210147T1 (de) Glycokonjugate von modifizierten camptothecin- derivaten(a- oder b-ring-verknüpfung)
GEP20002206B (en) Cryptophycins, Method for its Production, Pharmaceutical Composition on Their basis and Use
GEP20053617B (en) Bridged Piperazine Derivatives
ATE184793T1 (de) Die verwendung von carbostyrilderivaten zur herstellung eines arzneimittels zur hemmung der produktion von interleukin-8
LV11728A (lv) Farmaceitiska kompozicija
RU94044357A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования увеличения веса, индуцирования снижения веса или ингибирования аппетита
DK0609336T3 (da) Anvendelse af prostacyclin-derivater til forebyggelse eller behandling af lidelser i mikrocirkulationssystemet ved administ
AU3862997A (en) Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof
ATE190845T1 (de) Rektale flunisolid-zubereitung zur behandlung entzündlicher darmerkrankungen
DE69429447T2 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
FI970452A0 (fi) Leukotrieenin biosynteesin estäminen ureajohdannaisten avulla
ATE269704T1 (de) Pyrroloazepinderivate enthaltende arzneimittel zur behandlung von claudicatio intermittens
AU1466592A (en) Gem-diphosphonic acid nitrosocarbamoyl derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
NZ304823A (en) Beta carboline derivatives and medicaments
DE69429538T2 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen
ATE300304T1 (de) Verwendung von xanthinederivaten zur herstellung eines arzneimittels zur behandlung oder verhütung von osteoporose
ES2026755A6 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene 3&#39;-azido-3&#39;-desoxitimidina o uno de sus derivados farmaceuticamente aceptables.
UA27023C2 (uk) Спосіб профілактики та лікуваhhя серцево-судиhhих захворюваhь

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110806